ROGER RIVERA: Open Payments
NPI 1730697715 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489,885 in 615 payments from 10 companies in 2025. Trend: 2023 $370,277 · 2024 $455,807 · 2025 $489,885
Speaker / faculty: $283,646Travel & lodging: $132,924Honoraria: $49,891Food & beverage: $12,431Consulting: $10,993
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 155 | $147,653 |
| Vanda Pharmaceuticals Inc. | 148 | $109,887 |
| Axsome Therapeutics, Inc. | 112 | $73,442 |
| Neurocrine BioSciences, Inc. | 62 | $59,215 |
| Alkermes, Inc. | 48 | $37,763 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $23,426 |
| E.R. Squibb & Sons, L.L.C. | 35 | $19,476 |
| Teva Pharmaceuticals USA, Inc. | 13 | $17,382 |
| Otsuka America Pharmaceutical, Inc. | 3 | $1,548 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
Products named: VRAYLAR, FANAPT, Auvelity, INGREZZA, LYBALVI, CAPLYTA, COBENFY, UZEDY.
Industry payments across FL — which companies pay providers there.
